Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Funding

Deals  ·  Weekly Digest - 29 August to 04 September 2026
DualityBio enters global collaboration with Roche to develop next-generation ADCs using the DUPAC novel-payload platform

Weekly Digest – September 2026 Weekly Digest – September 2026 28 August 2026: DualityBio enters global collaboration with Roche to develop next-generation ADCs using the DUPAC novel-payload platform DualityBio announced a global collaboration and license agreement with Roche to develop […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 29 August to 04 September 2026
HUTCHMED announces licensing agreement with GSK for KRAS-EGFR antibody conjugate cancer therapy

Weekly Digest – September 2026 Weekly Digest – September 2026 03 September 2026: HUTCHMED announces licensing agreement with GSK for KRAS-EGFR antibody conjugate cancer therapy HUTCHMED announced an exclusive licensing agreement with GSK for HMPL-A830, a first-in-class KRAS-EGFR antibody-targeted therapy […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 22 August to 28 August 2026
Trodelvy expanded to 1L metastatic TNBC Across PD-L1 Status in the EU

Weekly Digest – August 2026 Weekly Digest – August 2026 24 August 2026: Trodelvy expanded to 1L metastatic TNBC Across PD-L1 Status in the EU Gilead announced that the European Commission has approved Trodelvy plus Keytruda for the first-line treatment […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 22 August to 28 August 2026
Novartis’ Pluvicto receives approval in China for a new indication

Weekly Digest – August 2026 Weekly Digest – August 2026 26 August 2026: Novartis’ Pluvicto receives approval in China for a new indication Novartis announced that China’s NMPA approved a new indication for Pluvicto in combination with an androgen receptor […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 22 August to 28 August 2026
DualityBio’s DB-1317 granted FDA Fast Track Designation for advanced PDAC

Weekly Digest – August 2026 Weekly Digest – August 2026 25 August 2026: DualityBio’s DB-1317 granted FDA Fast Track Designation for advanced PDAC DualityBio announced that its ADAM9-targeted ADC candidate DB-1317 has been granted Fast Track Designation by the U.S. […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 22 August to 28 August 2026
SOTIO’s SOT106 granted FDA Fast Track Designation for Soft Tissue Sarcoma

Weekly Digest – August 2026 Weekly Digest – August 2026 26 August 2026: SOTIO’s SOT106 granted FDA Fast Track Designation for Soft Tissue Sarcoma SOTIO announced that the U.S. FDA has granted Fast Track Designation to SOT106, an LRRC15-targeted ADC, […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 22 August to 28 August 2026
Datroway phase 3 TROPION-Urothelial04 trial initiated as adjuvant therapy for high-risk MIUC

Weekly Digest – August 2026 Weekly Digest – August 2026 26 August 2026: Datroway phase 3 TROPION-Urothelial04 trial initiated as adjuvant therapy for high-risk MIUC Daiichi Sankyo and AstraZeneca announced the initiation of the phase 3 TROPION-Urothelial04 trial, with the […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 22 August to 28 August 2026
CSPC announced that SYS6010 met the pre-specified primary endpoint in phase 3 trial

Weekly Digest – August 2026 Weekly Digest – August 2026 26 August 2026: CSPC announced that SYS6010 met the pre-specified primary endpoint in phase 3 trial CSPC Pharmaceutical Group announced that its EGFR-targeted ADC SYS6010 met the pre-specified primary endpoint […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 15 August to 21 August 2026
GSK’s Blenrep combination approved in Singapore for treatment of relapsed/refractory Multiple myeloma

Weekly Digest – August 2026 Weekly Digest – August 2026 19 August 2026: GSK’s Blenrep combination approved in Singapore for treatment of relapsed/refractory Multiple myeloma GSK announced that Singapore’s Health Sciences Authority has approved Blenrep in combination with bortezomib plus […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 15 August to 21 August 2026
Akeso’s AK157D1 cleared for phase 1 trial in Solid tumors

Weekly Digest – August 2026 Weekly Digest – August 2026 21 August 2026: Akeso’s AK157D1 cleared for phase 1 trial in Solid tumors Akeso announced that its B7-H3-targeted ADC candidate AK157D1 has been cleared by China’s NMPA Center for Drug […]

by Sandhya Ramalingam

Continue Reading
« First‹ Previous456789101112Next ›Last »
Page 8 of 63


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id